Menu
Curie Logo
Donate
  • Home >
  • Publications >
  • Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆

1 Oct 2020Annals of Oncology

DOI : 10.1016/j.annonc.2020.06.020

Authors

F. Montemurro, S. Delaloge, C.H. Barrios, R. Wuerstlein, A. Anton, E. Brain, T. Hatschek, C.M. Kelly, C. Peña-Murillo, M. Yilmaz, M. Donica, P. Ellis